Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Gkb Ophthalmics
Join Channel
Consolidated Standalone

GKB Ophthalmics

₹100.5 1.2 | 1.2%

Market Cap ₹51 Cr.

Stock P/E -13.3

P/B 0.8

Current Price ₹100.5

Book Value ₹ 120.4

Face Value 10

52W High ₹136.4

Dividend Yield 0%

52W Low ₹ 74.1

Edit Ratio

GKB Ophthalmics Research see more...

Overview Inc. Year: 1981Industry: Medical Equipment/Supplies/Accessories

GKB Ophthalmics Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

GKB Ophthalmics Quarterly Results

#(Fig in Cr.) Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 19 20 17 18 19 19 20 22 20 24
Other Income 0 0 0 0 0 -0 0 0 0 0
Total Income 19 20 18 18 19 19 20 23 21 24
Total Expenditure 18 18 16 15 17 19 20 21 21 25
Operating Profit 1 2 2 3 2 -0 -0 2 0 -0
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 1 1 1 0 0 0 2 1 1 1
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -0 1 1 2 1 -1 -2 1 -1 -1
Provision for Tax 0 0 -0 -0 -0 0 -0 0 0 0
Profit After Tax -0 1 1 2 1 -1 -2 1 -1 -1
Adjustments -0 -0 -0 -0 -0 0 0 -0 0 0
Profit After Adjustments -0 1 1 2 1 -1 -2 1 -1 -1
Adjusted Earnings Per Share -0.7 1.6 1.3 3.8 1.7 -2.1 -3.8 1 -2.3 -2.5

GKB Ophthalmics Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 43 41 35 44 74 77 57 59 57 71 75 86
Other Income 1 1 1 2 1 0 2 0 2 1 1 0
Total Income 43 42 36 46 75 78 59 59 59 72 76 88
Total Expenditure 40 34 34 46 72 76 56 56 55 66 72 87
Operating Profit 4 8 1 0 3 2 3 3 4 6 5 2
Interest 3 3 2 2 1 1 1 1 2 1 2 0
Depreciation 1 1 2 1 1 2 4 4 3 3 3 5
Exceptional Income / Expenses -1 0 1 11 3 0 0 0 -1 0 0 0
Profit Before Tax -1 5 -2 8 3 -1 -2 -2 -1 2 0 -3
Provision for Tax -0 2 -1 4 0 -0 -0 0 -0 0 0 0
Profit After Tax -1 2 -1 4 3 -1 -1 -2 -1 2 0 -3
Adjustments 0 2 1 0 0 0 0 1 -0 -1 -0 0
Profit After Adjustments -1 4 0 4 3 -1 -1 -2 -1 1 -0 -3
Adjusted Earnings Per Share -1.7 9.6 0 9.5 6.2 -2.3 -2.4 -3.6 -1.8 2.5 -0.3 -7.6

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 6% 8% -1% 6%
Operating Profit CAGR -17% 19% 20% 2%
PAT CAGR -100% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -14% 14% 2% 14%
ROE Average 0% 1% -1% 1%
ROCE Average 2% 3% 1% 5%

GKB Ophthalmics Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 35 40 40 45 47 45 55 59 63 63 63
Minority's Interest 0 0 0 0 0 0 0 0 4 4 5
Borrowings 2 2 0 0 0 0 0 0 1 2 1
Other Non-Current Liabilities 1 1 1 2 2 2 5 5 5 6 6
Total Current Liabilities 34 30 33 23 37 36 37 41 38 39 41
Total Liabilities 73 73 75 69 86 83 97 106 111 114 116
Fixed Assets 13 14 12 13 18 18 26 26 24 23 19
Other Non-Current Assets 15 16 17 5 2 1 7 7 13 16 13
Total Current Assets 45 43 46 51 66 64 64 73 74 76 84
Total Assets 73 73 75 69 86 83 97 106 111 114 116

GKB Ophthalmics Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 2 2 2 3 3 2 2 9 13 6 6
Cash Flow from Operating Activities 3 6 7 -11 -3 -3 4 3 7 5 -3
Cash Flow from Investing Activities -2 -2 -0 15 4 1 -10 -4 -17 -4 1
Cash Flow from Financing Activities -1 -5 -6 -3 -1 1 13 4 3 -2 -2
Net Cash Inflow / Outflow 1 -0 1 0 -1 0 7 4 -7 -0 -4
Closing Cash & Cash Equivalent 2 2 3 3 2 2 9 13 6 6 2

GKB Ophthalmics Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) -1.69 9.61 0.01 9.51 6.23 -2.34 -2.38 -3.65 -1.8 2.53 -0.33
CEPS(Rs) 0.23 8.88 0.57 13.1 9.68 1.75 4.99 2.32 4.75 9.15 5.84
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 84.17 96.06 96.33 107.89 112.64 108.2 111.84 117.55 124.3 125.18 124.38
Core EBITDA Margin(%) 7.14 17.89 2.28 -3.82 2.39 1.72 2 3.65 3.37 6.83 4.88
EBIT Margin(%) 3.82 17.59 1.13 20.91 5.54 0.18 -0.37 -1.69 1.94 4.83 2.4
Pre Tax Margin(%) -2.8 10.84 -5.65 17.33 3.85 -1.46 -2.97 -4.19 -1.63 2.74 0.18
PAT Margin (%) -2.5 5.85 -3.57 8.67 3.38 -1.25 -2.14 -4.19 -1.32 2.74 0.15
Cash Profit Margin (%) 0.22 8.72 0.64 11.93 5.26 0.93 4.05 2 4.21 6.5 3.9
ROA(%) -1.52 3.39 -1.78 5.48 3.34 -1.15 -1.36 -2.41 -0.69 1.73 0.1
ROE(%) -3.1 6.6 -3.3 9.32 5.65 -2.12 -2.52 -4.41 -1.23 3.09 0.18
ROCE(%) 3.36 14.52 0.82 18.94 7.99 0.25 -0.34 -1.38 1.48 4.58 2.44
Receivable days 155.87 170.23 194.91 142.03 99.83 122.19 162.83 151.07 142.44 100.29 114.24
Inventory Days 191.9 183.07 200.66 169.82 124.36 147.17 190.76 181.31 211.22 188.1 184.84
Payable days 171.25 173.66 265.65 192.73 126.99 165.17 231.94 221.09 234.2 200.8 190.02
PER(x) 0 3.03 4892.03 6.94 21.4 0 0 0 0 36.39 0
Price/Book(x) 0.22 0.3 0.52 0.61 1.18 1.07 0.83 0.37 0.66 0.73 0.87
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.46 0.54 0.75 0.7 0.81 0.72 0.82 0.39 0.63 0.59 0.68
EV/Core EBITDA(x) 5.31 2.69 18.01 626.24 19.06 30.3 14.15 8.74 8.29 6.95 11.17
Net Sales Growth(%) 10.5 -3.15 -15.13 24.38 69.3 4.5 -26.17 2.4 -2.83 24.72 6.4
EBIT Growth(%) -75.18 346.84 -94.41 2193.92 -55.59 -96.77 -255.89 -362.64 211.85 210.17 -47.08
PAT Growth(%) -133.68 327.18 -153.28 400.08 -34.53 -137.52 -25.86 -100.59 69.46 359.73 -94.02
EPS Growth(%) -105.88 669.13 -99.89 0 -34.53 -137.52 -1.8 -53.4 50.67 240.42 -113.14
Debt/Equity(x) 0.43 0.31 0.22 0.16 0.15 0.22 0.27 0.26 0.19 0.19 0.18
Current Ratio(x) 1.33 1.44 1.38 2.25 1.8 1.75 1.72 1.76 1.94 1.95 2.02
Quick Ratio(x) 0.66 0.8 0.75 1.32 0.96 0.87 0.97 1.02 1.01 0.98 1.09
Interest Cover(x) 0.58 2.6 0.17 5.84 3.28 0.11 -0.14 -0.67 0.54 2.32 1.08
Total Debt/Mcap(x) 1.98 1.03 0.41 0.26 0.13 0.21 0.33 0.7 0.29 0.25 0.2

GKB Ophthalmics Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 59.69 59.72 59.73 59.16 59.09 59.09 59.18 50.86 50.88 50.93
FII 1.98 1.98 1.98 1.98 1.98 1.79 1.79 1.79 1.79 1.79
DII 0 0 0 0 0 0 0 0 0 0
Public 38.33 38.29 38.28 38.86 38.93 39.12 39.03 47.35 47.33 47.28
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Stock is trading at 0.8 times its book value
  • Debtor days have improved from 200.8 to 190.02days.
  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Company has a low return on equity of 1% over the last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

GKB Ophthalmics News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!